Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
“Plasma Diplomacy: How Plasma Is Becoming a Strategic Healthcare Commodity
For decades, plasma was viewed simply as a life-saving medical resource. Today, it has become something far more powerful: a strategic asset shaping national healthcare security, global trade, and geopolitical influence.
In this issue of Blood and Plasma Pulse, we explore a critical but under-discussed reality:
- Why plasma is no longer just a clinical input, but a tool of national resilience
- How a handful of countries now control the majority of global plasma supply
- What “plasma sovereignty” means for healthcare systems and patient access
- How plasma is influencing international alliances, supply agreements, and policy decisions
As demand for plasma-derived therapies accelerates and supply remains highly concentrated, the question is no longer about who donates plasma but who controls its future.
This edition dives into the emerging concept of Plasma Diplomacy, where healthcare, strategy, economics, and global cooperation intersect through a single biological resource.
Is plasma becoming the next strategic healthcare commodity on the global stage?”

Read full paper here.
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care